Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
The electrocardiogram (ECG) is a valuable tool for assessing the cardiac conduction system. The measurements routinely obtained with ECG include heart rate, PR interval, QRS duration and the QT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results